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ABSTRACT 
Objective: To conduct a randomized, controlled, two-stage trial in the treatment of bulimia 
nervosa, comparing cognitive behavioural therapy (CBT) versus motivational enhancement in 
Phase 1 followed by group versus individual CBT in Phase 2. 
Methods: A total of 225 patients with bulimia nervosa or eating disorder not otherwise 
specified (EDNOS) were recruited into a randomized controlled trial lasting 12 weeks with 
follow-ups at 1 year and 2.5 years. Results: Patients improved significantly across all of the 
interventions with no differences in outcome or treatment adherence. Including motivational 
enhancement therapy rather than a CBT first phase of treatment did not affect outcome. 
Conclusions: Outcome differences between individual and group CBT were minor, 
suggesting that group treatment prefaced by a short individual intervention may be a cost-
effective alternative to purely individual treatment. 
 
Key words: bulimia nervosa, group cognitive-behavioral therapy, motivational enhancement 
therapy, randomized controlled trial. 
 
 
  
INTRODUCTION 
The National Institute for Clinical Excellence Guidelines for Eating Disorders (1) 
recommend that a specific form of cognitive-behavior therapy for bulimia nervosa (CBT-BN) 
(2) should be given to most adults. The statement was based on evidence from randomized 
controlled trials, which generally assess the efficacy of treatment under optimal conditions 
(highly selected patients, recruited via advertisements and treatment delivered by research 
clinicians with tightly controlled treatment procedures). Many patients presenting to 
outpatient services do not have full syndromal bulimia nervosa (BN) and instead present with 
subthreshold or partial syndromes (3)’ very few studies (4 –7) of reasonable size (i.e., 
100 participants) have included these patients. Thus, little is known about the effectiveness of 
CBT-BN under routine clinical conditions (8), where treatments are delivered by 
ordinary therapists to patients with symptoms that do not neatly fit the diagnostic category of 
BN (i.e., those with eating disorder not otherwise specified [EDNOS]). 
 
Recent efficacy studies (9 –11), which have compared group with individual CBT, suggested 
a slight advantage of individual over group treatment in terms of clinical outcomes, in part, 
because there is less adherence to group treatment. In routine clinical practice, dropout from 
individual CBT is high (approximately 40% to 50%), whether delivered individually or in a 
group setting (12,13). The failure to adhere to a treatment with proven effectiveness suggests 
that there may be a problem in readiness to change. Motivational interviewing is an 
intervention, which was developed to address just such concerns, and when offered as a 
prelude to other forms of psychological treatment, such as CBT, has produced synergistic 
effects (14). Motivational interventions given in the first phase of treatment for people with 
eating disorders have been found to improve outcome (15,16) and increase readiness to 
change (15). The addition of a Motivational Interviewing component as a prelude to group 
treatment might augment the commitment to behavior change. 
 
The present study reflects a pragmatic clinical trial under routine conditions in a busy 
outpatient setting, to examine whether a) motivational enhancement therapy (MET) before 
individual (MET-I) or group delivery of CBT (MET-G) will reduce dropout and improve 
outcome in patients with BN or EDNOS compared with participants who received purely 
CBT both before and during group care (CBT-G); and b) whether group treatment (MET-G 
and CBT-G) can produce similar clinical outcomes compared with a purely individual 
treatment of the same duration (MET-I). 
 
METHODS 
Subjects 
Patients were recruited from consecutive primary care or secondary care referrals to a 
catchment area-based NHS eating disorder service. All patients fulfilling the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition criteria for BN or EDNOS were 
eligible for the study. The exclusion criteria were pregnancy, diabetes mellitus, severe mental 
illness (such as schizophrenia or bipolar illness), severe learning disability, inability to 
commit to treatment from the outset, or referral for assessment only. We defined EDNOS as 
subthreshold BN—a clinically relevant eating disorder (i.e., significant impairment of 
physical health or psychosocial functioning) where the patient met the criteria for BN except 
that the binge eating and/or inappropriate compensatory behaviors occurred at a frequency of 
less than twice a week or for a duration of                                                3 months. In our 
sample of 225, 60 were diagnosed with EDNOS. The study was approved by the Ethics 
Committee of the Institute of Psychiatry and South London and Maudsley NHS Trust and 
took place over a 4.5-year period, beginning late 1997 and ending in 2002. 
 
Sample Size 
The sample size calculation took into account a difference that might be considered to be 
clinically significant between groups in this population. We calculated that a sample size of 
64 patients per treatment condition was required to provide 80% power at two-sided p < .05 
to detect a difference of .5 in the size of the effect of change in symptom frequency. To 
account for dropout, we increased the sample to 75 per group. 
 
Randomization 
An independent investigator, using a table of random numbers, generated the randomization 
sequence. Allocations were contained in sequentially numbered, sealed, opaque envelopes 
opened by the clinician after the initial assessment, during which eligibility and willingness to 
participate were determined. 
 
Study Design 
A three-group, two-phase study design was adopted with patients being allocated to either 
four sessions of individual MET followed by eight sessions of individual CBT (MET-I), four 
sessions of individual MET followed by eight sessions group CBT (MET-G), or four sessions 
of individual CBT followed by eight sessions of group CBT (CBT-G). 
 
Phase 1 
Phase 1 consisted of four individual sessions of either manualized individual MET or 
individual CBT for BN. 
 MET 
In MET, the therapist used principles of motivational interviewing and accompanying 
worksheets guided by the manual “A Clinician’s Guide to Getting Better Bit(e) by Bit(e)” 
(17). Treatment focused on a consideration of the benefits of changing and the barriers to be 
overcome to change, moving from the here and now by envisioning key values and how these 
would fit into the whole life story. No unsolicited advice about eating was given. All 
participants in this condition received a letter providing personalized feedback on physical 
symptoms, laboratory tests, and detailed social, family, educational, and vocational problems 
found at the time of assessment. This feedback was reviewed by patient and therapist during 
the first session. Behavior change techniques included: outcome expectancies, personal 
relevance, descriptive norms, developing personal and moral norms and if the patient showed 
a commitment to change, concrete planning and contracting of behavioral goals (17). 
 
CBT 
In the CBT condition, therapists followed the instructions of the first four chapters of 
“bulimia nervosa“ (18) and included active strategies of behaviour change from session 1, 
including nutritional/food monitoring sheets, meal planning, activity lists, and problem-
solving activities. At the time of the study, this was the only CBT self-help manual available 
with proven efficacy in the treatment of BN. This manual does not specifically focus on 
increasing motivation. 
 
Phase 2 
Phase 2 consisted of eight sessions of individual or group CBT. In both conditions, patients 
worked with the manual, “You Can’t Have Your Cake and Eat It Too: A Progam for 
Controlling Bulimia” (19). The structure of Phase 2 sessions followed the chapter topics of 
the book. Each week included discussion and exercises to educate women about the physical 
and psychological hazards of eating disorders, challenging myths, and identifying ways 
women might undermine their own success. During weekly sessions, therapists integrated 
nutritional information (realistic caloric consumption, meal planning, etc.) and methods to 
modify extreme, unhelpful thinking. Perfectionist ideas about one’s body and behavior were 
identified and ways to assert one’s feelings and express anger were reviewed. Women 
discussed basic human rights; obstacles to feeling satisfied in their relationships and 
evaluated which relationships are “nourishing.” They engaged in role plays to tackle 
interpersonal problems and were encouraged to use the group to test new behaviors. Women 
identified media expectations for appearance and brought in pictures of their real and ideal 
body. Exercises included ways to appreciate the function, not the form of their body, and 
participants experimented with making changes in attractive behaviors, rather than weight. 
Everyone kept a diary, which was collected each week and returned the next week with 
written suggestions and encouragement by the therapist. Progress was recorded each week on 
a standing flip chart (if in group) or on a graph (if in individual care), and any movement 
toward decreasing or delaying binges was recognized. The flip chart was also used to capture 
the work of each exercise and was reviewed by participants over the course of the group as 
different activities referenced back to each other. The chart was also used during supervision. 
As the group progressed, the diary work became increasingly focused on aiding women to 
use the I.C.O.P.E. method (20) which involved: Identifying the problem, Communicating the 
issues more assertively, Organizing one’s time for maximum benefit-setting limits, 
Perceiving things realistically and positively (whether it be their bodies or their behaviors), 
and Enhancing one’s self-esteem through nourishing actions and relationships. Individual 
sessions lasted 50 minutes. Group sessions lasted 90 minutes, had between six to eight 
participants, and were moderated by two therapists. To ensure continuity, therapists running 
groups also saw patients for Phase 1 treatments so that each group participant had one of the 
two co-leaders as their therapist during the first four sessions. Both co-leaders played equal 
roles. 
 
In contrast to the well-known CBT-BN program of Fairburn and colleagues (2), the group 
treatment used here (19,21) is briefer (8 versus 19 sessions) and emphasized women’s 
development of interpersonal competencies. 
 
Therapist Training and Supervision 
Therapists were all drawn from health service personnel in the Eating Disorders Unit at the 
Maudsley Hospital and included psychologists, psychiatrists, nurses, or occupational 
therapists, all of whom were experienced in the treatment of eating disorders and the delivery 
of MET and CBT. To avoid therapist bias, all therapists delivered the three conditions. All 
received the following: MET training during a 2-day workshop; a training day on the use of 
the group program; and a 2-day workshop on the delivery of manual-guided CBT. Weekly 
supervision was mandatory for all therapists and was conducted on a one:one basis for 
individual treatment and with co-therapists for the group intervention. Supervision 
arrangements for the first 4 weeks of treatment were kept strictly separate and conducted by 
separate supervisors who were either experienced CBT (Padmal de Silva) or MET trainers 
(J.T., U.S.). Dr. Katzman provided supervision to all three experimental groups during the 
last 8 weeks of the trial, again with separate supervision for cases being treated in individual 
or group treatment. During the first 4 weeks, all treatment conditions (MET-I, MET-G, CBT-
G) generated a “product” (thought records, motivational letters, etc). These were checked for 
quality in supervision. Moreover, precisely how materials were used in therapy and integrated 
into the treatment of different patients was reviewed in supervision on a regular basis. In 
Phase 2, all diaries and flip charts were collected weekly and reviewed by supervisors. 
 
Assessment 
All patients were assessed for suitability by an experienced clinician, using a standardized 
semi-structured interview format (22–24). The English version of the interview was 
developed by eating disorder experts in the context of a European project (COST ACTION 
B6). Previous versions of the interview had been used in a large German multi-center, 
naturalistic study on outcome of eating disorders (project TREAT) (22). The interview 
included variables from the LIFE (24) and the EDE (23) assessing eating disorder symptoms, 
use of drugs, and alcohol and antidepressant medication. A pre-treatment battery (22) 
included basic clinical features and demographics, along with well-validated, widely used 
questionnaires, such as the Symptom Checklist 90 (25). The primary treatment outcomes 
were key behavioral symptoms (binge eating, self-induced vomiting, laxative/diuretics abuse) 
that were measured, using the short evaluation of eating disorders (26 –28). This is a brief, 
valid, and reliable self-report measure assessing eating disorder symptoms over the last 4 
weeks. There is excellent interrater reliability with values of > 0.70 between patient self-
ratings and those independently made by an “expert” (therapist or clinical researcher). 
Patients and therapists rated these variables separately at pretreatment, 4 weeks (after Phase 
1) and at 12 weeks (after Phase 2). Only patient ratings collected by research assistants 
blinded to their treatment allocation are available for the 1-year follow-up and the 2.5-year 
follow-up. All outcomes were assessed for the time period of the previous month. 
 
An additional outcome variable, motivation to change and dropout, was assessed with the 
University of Rhode Island, Change Assessment Scale (29). This questionnaire, completed by 
the patient, offers four scales—precontemplation, contemplation, action, and maintenance—
as well as assigning patients to a particular stage on the basis of the scale with the highest 
score. 
 
Definitions of Treatment Completion and Dropout 
There is little agreement between studies on how to define treatment adherence and dropout. 
We used completion of treatment phases as a proxy of treatment adherence. Phase 1 
treatment (MET or CBT) completion was defined as attendance at all four individual 
sessions. Completion of Phase 2 treatment (individual or group CBT) was defined as 
attendance at ≥ 6 of eight possible sessions. Dropout was defined as Phase 1 completed and 
Phase 2 not completed or non-completion of Phase 1 and Phase 2 treatment. 
 
Analysis 
Demographic information and baseline data were analyzed, using SPSS 8.0 (SPSS, Inc., 
Chicago, Illinois) for windows. Data were compared using t-tests, analysis of variance, or χ2. 
Eating disorder symptomatology was analyzed, using the Stata program gllamm (30). For 
this, analysis outcomes for eating disorder symptoms (bingeing, vomiting, laxative use) were 
examined separately to determine whether motivational pre-treatment might have a different 
effect on different symptoms (given that clinical experience suggests that patients’ motivation 
to change differs between symptoms). 
 
The patient and therapist ratings of the frequency of bingeing, vomiting, and use of laxatives 
were collapsed into three comparable and clinically relevant categories: 0 = abstinence; 1 = 
infrequent behaviors (i.e., < 2 times a week); and 2 = frequent behaviors (≥ 2 times a week). 
 
Therapist and patient ratings of each type of behavior were analyzed separately. A 
proportional odds model for repeated measures was used to model the effect of treatment, 
time, and time by treatment on the odds of being rated in the higher categories (2 versus 1, 0 
or 2, 1 versus 0). A random effect for subjects was included in the model to take account of 
correlations among the observations on the same subject. The effect of time was modeled by 
a linear trend in the log-odds. The significance of the interaction was tested, using a Wald 
test. If significant, the linear trend of time was compared between the groups with and 
without motivational enhancement therapy and between the group treatment and individual 
treatment groups. If the group by time interaction was not significant, the model was re-
estimated with the main effects of group and time only. 
 
Our analyses were based on intention to treat, which meant that although each subject 
contributed different numbers of observations, we were able to make more efficient use of the 
data than the more common complete case analysis used for repeated-measures data. This 
approach also allowed us to analyze whether specific variables, such as dropout or stage of 
change, predicted outcome. The parameters were estimated by maximum likelihood, using 
adaptive quadrature. Maximum likelihood estimation provides consistent parameter estimates 
if the data are missing at random. 
 
RESULTS 
Recruitment and Progression of Patients Through the Study 
Figure 1 provides a CONSORT diagram of patient recruitment and their progression through 
the study. 
 
Figure 1 about here 
 Baseline Data 
As shown in Table 1, analysis of variance revealed no significant differences between any of 
the three groups on baseline characteristics apart from a difference in age, which although 
statistically significant (p < .05) was not clinically meaningful (mean age, 29.3 years; MET-I, 
31.0 years; MET-G, 28.9 years; CBT-G, 27.8 years). For the groups combined, the average 
body mass index (kg/m
2
) was 24.7 (7.5). 
 
Table 1 about here 
 
The three groups reported no difference at baseline on bingeing, vomiting, or laxative use. 
These variables were rated, using a 5-point scale (“1 = not at all,” “2 = up to 1× per week,” “3 
= 2 to 3× per week,” “4 = 4× per week up to daily,” “5 = > 1× day”). It is of note that 
considerable proportions of patients took antidepressant medication, (42.4% of the 172 
patients for whom this information was available), used alcohol regularly (51.5% of the 165 
patients for whom this information was available) or were taking illicit drugs (42.1% of the 
155 patients for whom this information was available). The participants drank between 4 
times a week to daily (10% drank more than once daily). This suggests high levels of 
comorbid substance abuse and depression, which did not differ between groups (Pearson’s χ2 
= 1.306, p = .520 when comparing groups on use of antidepressant medication; Pearson’s χ2 
= 15.290, p = .054 comparing groups on alcohol use and Pearson’s χ2 of 8.698, p = .368 on 
illicit drug use). 
 
Treatment Uptake, Adherence, and Dropout 
There were no significant differences in treatment uptake, completion, and dropout between 
groups (Fig. 2). Patient ratings of symptom abstinence beginning to end of treatment are 
illustrated in Table 2. 
 
Figure 2 about here 
Table 2 about here 
 
Bingeing 
Therapist Rating 
There was no significant group by time interaction (p = .79). The odds of bingeing decreased 
over time (p < .001; odds ratio [OR], 0.32; 95% confidence interval [CI], 0.19–0.53). Stage 
of change, Symptom Checklist-90 (SCL-90), and completion of Phase 1 had no significant 
effect on outcome. 
 
Patient Rating 
There was no significant group by time interaction (p = .64). The reduction in the odds of 
bingeing over time was significant (p < .001; OR, 0.39; 95% CI, 0.31– 0.49). The patient 
rating of bingeing over time tended to be lower if the patient was in a higher stage of change 
at the time of assessment (p = .02), i.e., more motivated. The SCL-90 and completion of 
Phase 1 had no significant effect on the patient ratings of bingeing. 
 
Self-Induced Vomiting 
Therapist Rating 
Vomiting as rated by the therapist did not show a significant group by time interaction (p = 
.62). There was a significant main effect of time. At every assessment, the odds of vomiting 
decreased to 36% of its value at the previous assessment (p < .001; OR, 0.36; 95% CI, 0.25– 
0.53). Completion of the first treatment phase significantly reduced the odds of vomiting 
(OR, 0.28; p = .05; 95% CI, 0.08 –1.01). Scores on the SCL-90, stage of change and dropout 
had no significant effect. 
 
Patient Rating 
The patient rating showed no significant group by time interaction (p = .61). The odds of 
vomiting decreased significantly over time (p < .001; OR, 0.46; 95% CI, 0.36–0.58). 
Completion of the first treatment phase significantly reduced the odds of vomiting (OR, 0.29; 
p = .05; 95% CI, 0.09–0.99). SCL-90 scores and stage of change had no significant effect on 
outcome. 
 
Laxative or Diuretic Use 
Therapist Rating 
The therapist rating of laxative/diuretic use showed a significant group by time interaction (p 
= .03). The effect of time differed significantly between the condition which received MET-G 
and the condition which received MET-I (p = .01) and not between any other pairs. The effect 
of time was not significant in the MET-G condition (p = .21) but was significant in the CBT-
G (p = .01; OR, 0.39; 95% CI, 0.19–0.81) and in the MET-I condition (p < .001; OR, 0.15; 
95% CI, 0.06–0.42). The two conditions which had group treatment in Phase 2 differed 
significantly from the condition which had individual treatment in Phase 2 (p = .03) but the 
conditions which had MET in Phase 1 did not differ significantly from the condition which 
had CBT throughout. The odds of laxative use were greater in the group that received group 
therapy. 
 
Completion of Phase I, SCL-90 and stage of change had no significant effect on the therapist 
rating of laxative use. 
 
Patient Rating 
The patient rating of laxative/diuretic use showed no significant group by time interaction (p 
= .45). There was a significant main effect of time, showing that the odds of laxative/diuretic 
use decreased (p < .001; OR, 0.53; 95% CI, 0.41– 0.70). The SCL-90 score predicted the 
odds of laxative/diuretic usage as judged by the patient (p = .006; OR, 4.22, 95% CI, 1.5–
11.86), but completion of Phase 1 and stage of change had no significant effect. 
 
Abstinence Rates 
Table 3 illustrates abstinence rates for bulimic behaviors over time as rated by the patients 
and therapists. 
 
Table 3 about here 
 
Given the lack of differences between the three groups on the key behavioral variables, 
overall abstinence rates were calculated for patient and therapist. For binge eating, the overall 
abstinence rates on the therapist assessment were 12.5% at baseline and 46% at post 
treatment. Patient rating of bingeing abstinence was 2.5% at baseline, 29% at post treatment, 
40% at 1-year follow-up, and 46% at 2.5-year follow-up. 
 
For self-induced vomiting, the overall abstinence rate by therapists was 23% at baseline and 
45% at post treatment. Patient rating of self-induced vomiting was 21% at baseline, 29% at 
post treatment, 54% at 1-year follow-up, and 46% at 2.5-year follow-up. 
 For abstinence from laxative/diuretic abuse, therapists rated 67% at baseline and 87% at post 
treatment. Patients reported abstinence rates of 59% at baseline, 75.3% at post-treatment, 
80% at 1-year follow-up, and 85% at 2.5-year follow-up. 
 
DISCUSSION 
This is a large-scale, pragmatic catchment area-based investigation of treatment effectiveness 
for bulimic disorders (BN and EDNOS). 
 
Main Findings 
Patients in all three conditions improved significantly on key behavioral outcomes (frequency 
of bingeing, vomiting, and laxative abuse). The degree of improvement on these parameters 
is in keeping with those found in other studies (1,31). It is noteworthy that patients reported 
more binge eating than therapists— perhaps because the patients themselves do not 
distinguish between subjective and objective binges. 
 
There were no differences between conditions on bingeing or vomiting (whether assessed by 
the patient or the therapist). While on the therapist rating of laxative abuse there was a 
significant group by time interaction, the patient rating of laxative use failed to confirm this. 
As only a small proportion of patients used laxatives, overall there is less certainty about this 
finding. 
 
There were no differences between groups in treatment up-take, completion, or dropout rates. 
The dropout rates found here, although higher than those reported in efficacy studies, were 
comparable to those reported in the context of other sample, using individual or group CBT 
in routine clinical settings (11,32). 
 
MET Versus CBT in the First Treatment Phase Our first hypothesis was that MET would 
improve treatment adherence and reduce dropout from treatment in patients with BN. This 
hypothesis was not supported. However, our findings do suggest that MET constitutes an 
acceptable alternative to CBT early in treatment, which is of both theoretical and practical 
importance. Theoretically, this is significant because MET involves different processes to 
CBT (33); the latter, for example, uses self-monitoring among other forms of action-
orientated behavior change principles in the early stages of treatment. It has been found that 
the response to CBT in the first six sessions is a strong predictor of later outcome 
(34). Those patients who find it difficult to comply with active strategies may respond better 
to MET. The majority of patients in this study were in the contemplation stage at baseline, 
and none were in precontemplation (35). Motivational interviewing is a less useful 
intervention in people who are ready to change (36). It is possible that the use of MET may 
be shown to be more effective in improving adherence and subsequent outcome in a less 
motivated group than the current sample who had sought clinical help. 
 
Group Versus Individual Treatment 
Our second hypothesis was that adding a brief individual component to group treatment can 
produce comparable results to solely individual treatment of the same duration. Patients in 
our study did equally well whether treated individually throughout or in an individual plus 
group setting in Phase 2. This finding counters past research, which suggests that group 
treatment produces higher dropout rates and may be less effective in reducing key behaviors, 
such as self-induced vomiting (37). 
 It is possible that our paper was underpowered to find statistical significance in abstinence 
rates between the group and individual conditions. However, it is worth considering several 
(not mutually exclusive) possibilities as to why the group worked as well (if not better) than 
the individual treatment program. These offer possible areas for future, more definitive 
research assessing group versus individual care. The short individualized prelude may have 
better prepared them for the group. Also, the therapist who saw the patient in the first phase 
of treatment was always one of the two therapists running the group to which the patient was 
allocated. This continuity and the patient’s knowledge that the therapist knew this person as 
an individual may have produced more positive outcomes. These optimistic findings for the 
use of group relative to individual care parallel those of Chen et al. (9), even though the 
programs were of different length and content. 
 
It is also notable that the length of our group treatment was 8 weeks, which is shorter than 
other group interventions described in the literature. However, Wolchik et al. (21) reported 
clinically significant findings after 7 weeks, and other investigators have reported that most 
change happens in the early phase of care (34). 
 
Overall, our findings suggest that, in routine clinical practice, with a few individual sessions 
at the start, group treatment is a valid and useful alternative to individual therapy. 
Importantly, group treatment may have advantages in terms of cost-effectiveness. In our 
setting, the total therapist time for one patient treated individually throughout was 
approximately 12 hours, whereas the therapist time for one patient treated in 
a group after four individual sessions was 8 hours. Obviously, more detailed cost-
effectiveness assessments are needed. 
 Predictors of Outcome 
We used psychiatric comorbidity as measured by the SCL-90, pre-treatment motivation 
(assessed by the stage of change measure, University of Rhode Island, Change Assessment 
Scale), and completion of the first treatment phase as predictors of outcome. These predictors 
were chosen because of their demonstrated importance in previous studies (34,35). 
 
Completion of the first treatment phase was the only variable to predict outcome on both 
patient and therapist assessment, and it only predicted outcome from vomiting. This is 
noteworthy, as early reduction of vomiting is an important predictor of longer-term treatment 
success (34). In the current study, long-term reduction in binge eating was predicted by the 
initial level of motivation. This supports earlier findings by Treasure et al. (35) in which 
improvement in binge eating was found for those subjects who shifted into an “active” stage 
of change. This also suggests that the stage of change may be specific for each of the 
behaviors (bingeing, vomiting, laxative abuse) and, therefore, should be assessed 
independently. That different behaviors may respond differently to treatment may advocate 
for interventions organized around symptoms, rather than diagnoses as suggested by the 
transdiagnostic model of Fairburn and colleagues (7,38). 
 
Limitations 
Our study was conducted with minimal resources under routine clinical conditions and, as a 
result, has a number of methodological limitations. Due to resource constraints, we did not 
include the “obvious” fourth treatment cell (four sessions CBT followed by eight sessions 
individual CBT). The inclusion of such a group would have been desirable, as it would have 
allowed us to assess whether MET enhances outcome relative to CBT, irrespective of 
whether it is followed by individual or group treatment. We also did not include a no-
treatment control group. This was neither practical nor given the pragmatic nature of the trial 
critical to understanding our results, as past studies, including one from our own center, did 
not show spontaneous improvement in the waiting list condition (39). 
 
We used patient ratings only for the long-term follow-up in keeping with previous large-scale 
naturalistic eating disorder outcome studies (27,28) Previous studies (40) have demonstrated 
excellent agreement between patient self-assessment tools and expert ratings on self-induced 
vomiting and on laxative use with lesser agreement on variables, such as bingeing, which 
require more subjective judgment. This is exactly what we found in the present study—
patient/clinician agreement on symptom frequency was better for vomiting and laxative use 
than for bingeing. However, overall, the inter-rater reliability between patients and therapists 
for symptoms measured in the present study was high. 
 
It should be noted that, although the assessor at follow-up was blinded, the assessors at post 
treatment were not blinded to outcome. 
 
We did not include a formal assessment of treatment fidelity or therapist competence through 
audio-taping of sessions because of resource constraints. However, therapists were regularly 
supervised, and all interventions used in this study were based on detailed manuals. 
Supervisors worked closely with therapists reviewing process notes and the products 
generated by the individuals or groups. 
 
We only assessed behavioral indicators of change, rather than including dietary restraint or 
attitudinal aspects of bulimic symptomatology, such as weight and shape. We omitted the 
latter, as they are more difficult to assess reliably (41). 
 
A number of our subjects were receiving antidepressant medication. We would not 
necessarily view this as a limitation, but rather, given the current status of pharmacological 
treatment of bulimia nervosa, we would view this as a fair reflection of clinic cases. 
Importantly, there were no differences between groups in this respect. 
 
We did not include a health economic assessment of patient’s total service use during and 
after treatment and we do not know how many of them received additional treatment for their 
eating disorder and whether there was any difference in this respect between the groups. 
However, given that we are the only NHS treatment center in the area, we can reasonably 
assume that no other NHS or specialized service was obtained. 
 
Finally, attrition rates were high but in keeping with those in relatively unselected clinic 
samples (11,32,42). Future studies might want to conduct qualitative interviews to assess the 
reasons for dropout, but resource constraints prohibited that in the current study. 
 
Strengths of the Study 
Although the study had a number of limitations, it also had a fair number of strengths. The 
sample size was large. Discussion at meetings and on the list serve of the Eating Disorders 
Research Society continually points to the gap between empirically supported treatments and 
typical clinical practice (43). Our study took our patients as we found them in our NHS clinic 
and very few were excluded from the protocol. 
Approximately one third of patients in the study suffered from EDNOS. Roughly 40% of 
patients were on antidepressants. A similar proportion took illicit drugs and just > 20% drank 
alcohol ≥ 4 times a week regularly, suggesting harmful use. Thus, a sizable subgroup of our 
patients would have been excluded from previous treatment trials (9,44). Moreover, in 
contrast to typical efficacy trials, our therapists were “ordinary” health professionals with 
widely differing levels of professional training and therapy experience, who had received 
only a modest amount of additional training in the study interventions, rather than highly 
trained “research therapists.” Thus, the study was conducted in an ecologically more 
“normal” environment than most other research trials in this area, and therefore fulfilled 
many of the elements of an effectiveness study. 
 
The inclusion of a long follow-up is an asset. Previously, treatment studies have rarely 
reported outcomes beyond 6 months to 1 year. In addition, the manualization of all treatments 
enhances generalizability and ability to disseminate. Furthermore, the interventions extend 
traditional CBT in two promising areas, MET and the development of interpersonal 
competencies. Finally, data modeling addresses limitations resulting from attrition. 
 
In their critique of treatment for BN two and a half decades since it first entered the 
Diagnostic and Statistical Manual of Mental Disorders, Mitchell and colleagues (45) state, 
“new approaches need to be piloted” as “the limits of current approaches are obvious.” We 
believe our study offers additional direction for just such alternative treatments. 
 
Further Considerations 
The overall “dose” of treatment (n  12 sessions) was relatively modest compared with other 
CBT packages, which are typically at least 16 to 20 sessions. It may be that a longer 
treatment package would have had added advantages in terms of improving outcomes in this 
group with high levels of comorbidity. Nonetheless, many patients showed good levels of 
improvement at the end of treatment comparable to those found in other studies, including the 
recent work of Fairburn and colleagues (7) that offered an enhanced CBT package, which 
included attention to interpersonal behaviors and perfectionism running for a total of 20 
weeks. The data do suggest that there may be more than one way to apply CBT in the 
treatment of BN, and that there may be viable, less costly alternatives to solely individual 
care. It is possible that MET may serve as a valuable addition to the therapist’s repertoire for 
cases that do not show a good initial response to CBT. 
 
Padmal de Silva was a co-investigator but died before the study’s publication. Padmal was 
born in Sri Lanka and trained as a clinical psychologist at the Maudsley Hospital, where he 
worked until his retirement. He is remembered as fantastic teacher and a wise and generous 
colleague with an acute sense of fun. 
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Table 1. Baseline data 
 
 Total n = 225 
Mean (SD) 
MET-I n = 79 
Mean (SD) 
MET-G n = 73 
Mean (SD) 
CBT-G n = 73 
Mean (SD) 
P* 
Age 29.3 (7.5) 31.0 (7.7) 28.9 (8.1) 27.8 (6.3) .02 
BMI 24.7 (7.6) 25.1 (7.7) 23.5 (5.9) 25.5 (8.9) .06 
Binges
a
 3.6 (1.4) 3.5 (1.5) 3.7 (1.4) 3.6 (1.4) .03 
Vomiting
a
 3.4 (1.7) 3.3 (1.7) 3.7 (1.6) 3.3 (1.6) .03 
Laxatives
a
 1.8 (1.6) 1.9 (1.4) 1.8 (1.4) 1.7 (1.3) .04 
 
a
 Coding frequency: “1 = not at all”; “2 = up to 1× week”; “3 = 2 to 3× week”; “4 = 4× week 
up to daily”; “5 = more 1× day.” 
*One-way analysis of variance, p value. 
MET-I = individual course of motivational enhancement therapy offered before individual 
cognitive therapy; MET-G = individual motivational enhancement therapy offered before 
cognitive behavior therapy group; CBT-G = individual cognitive behavior therapy offered 
before cognitive behavior therapy group; SD = standard deviation; BMI = body mass index. 
  
Table 2 
Group Behavior Assessment 
% (n) 
Week 4 
% (n) 
End of 
treatment 
% (n) 
1-year 
follow-up 
% (n) 
2.5-year 
follow-up 
% (n) 
MET-I Binge eating 0.0 (39) 6.1 (34) 25.0 (20) 57.7 (26) 40.0 (20) 
 Vomiting 17.8 (45) 32.3 (34) 25.0 (20) 57.7 (26) 40.0 (20) 
 Laxative use 66.7 (39) 71.0 (31) 72.2 (18) 71.0 (31) 81.8 (22) 
MET-G Binge eating 2.7 (37) 3.0 (30) 24.2 (33) 45.2 (31) 38.5 (13) 
 Vomiting 16.7 (36) 26.7 (30) 24.2 (33) 45.2 (19) 38.5 (21) 
 Laxative use 54.8 (31) 89.3 (28) 71.4 (28) 89.3 (28) 92.3 (13) 
CBT-G Binge eating 5.0 (40) 12.1 (36) 40.0 (20) 63.2 (19) 57.2 (21) 
 Vomiting 26.7 (45) 44.4 (36) 40.0 (20) 63.2 (19) 57.1 (21) 
 Laxative use 53.7 (41) 74.3 (35) 82.4 (17) 74.3 (35) 84.2 (19) 
 
 
MET-I = individual course of motivational enhancement therapy offered before individual 
cognitive therapy; MET-G = individual motivational enhancement therapy offered before 
cognitive behavior therapy group; CBT-G = individual cognitive behavior therapy offered 
before cognitive behavior therapy group; SD = standard deviation; BMI = body mass index. 
There was no significant group by time interaction on any of the behavioural variables. 
  
Table 3. Overall abstinence ratings over time for patient and therapist 
 
 Baseline 
% (n) 
End of treatment 
% (n) 
1-year follow-up 
% (n) 
1.5-year follow-
up 
% (n) 
Bingeing     
Patient 2.5 (38) 29 (32) 40 (22) 46 (17) 
Therapist 12.5 (70) 46 (18) N/A N/A 
Vomiting     
Patient 21 (45) 29 (35) 54 (23) 46 (20) 
Therapist 23 (72) 45 (37) N/A N/A 
Laxative use     
Patient 59 (40) 75 (33) 80 (33) 85 (16) 
Therapist 67 (66) 87 (35) N/A N/A 
 
N/A = not applicable 
 
  
Figure 1. Consort diagram 
 
 
MET-I = individual course of motivational enhancement therapy offered before individual 
cognitive therapy; MET-G = individual motivational enhancement therapy offered before 
cognitive behavior therapy group; CBT-G = individual cognitive behavior therapy offered 
before cognitive behavior therapy group. 
  
Figure 2. Treatment dropout by condition 
 
 
 
There were no significant differences between groups (p = .08). MET-I = individual course of 
motivational enhancement therapy offered before individual cognitive therapy; MET-G = 
individual motivational enhancement therapy offered before cognitive behavior therapy 
group; CBT-G = individual cognitive behavior therapy offered before cognitive behavior 
therapy group; MET = motivational enhancement therapy; CBT = cognitive-behavioral 
therapy. 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
41 
43 
48 
32 
45 
32 
43 
40 
Whole Indiv. CBT MET MET-I MET-G CBT-G Group 
